Responses
Clinical/translational cancer immunotherapy
Original research
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
Compose a Response to This Article
Other responses
No responses have been published for this article.
